Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2013

01.02.2013 | Basic Science

Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration

verfasst von: Renata T. Kashiwabuchi, Fabio R. S. Carvalho, Yasin A. Khan, Flavio Hirai, Mauro S. Campos, Peter J. McDonnell

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Corneal collagen cross-linking (CXL), a technique that combines riboflavin administration with long-wave ultraviolet light irradiation, was primarily developed to increase the biomechanical strength of collagen fibrils of the cornea to avoid the progression of keratoconus. Recently, this method has been proposed to treat selected cases of infectious keratitis.

Methods

To test the protocol used for progressive keratoconus in infectious keratitis, Candida albicans, and Fusarium solani, strains were exposed to irradiation using a wavelength of 365 nm at a power density of 3 mW/cm2 for 30 min in the presence of riboflavin photosensitizer. All experiments were performed in triplicate. Qualitative and quantitative measurements of fungal viability used plate cultures and an automated trypan blue dye exclusion method respectively. Fungal cell diameter was also assessed in all groups. Statistical analyses were performed using the triplicate values of each experimental condition.

Results

Experimental findings of photodynamic therapy applied to the cell inactivation of both yeasts and filamentous fungi were compared with control groups. Qualitative results were corroborated with quantitative findings which showed no statistical significance between challenged samples (experimental groups) and the control group (p-value = 1). In comparison with a control group of live cells, statistical significance was observed when riboflavin solution alone had an effect on the morphologic size of filamentous fungi, while ultraviolet light irradiation alone showed a slight decrease in the cell structure of C. albicans.

Conclusions

The impact of long-wave ultraviolet combined with riboflavin photosensitizer showed no antifungal effect on C. albicans and F. solani. The significant decrease in cell morphology of both filamentous fungi and yeasts submitted to photosensitizing riboflavin and exposure to ultraviolet light, respectively, may be promising in the development and standardization of alternatives for fungal cell inactivation, because of their minimal cytotoxic effects on the corneal surface. The methodological improvement in the preparation and application of individual chemical compounds, such as riboflavin, or physical systems, such as a long-wave light source, as antifungal agents may also assist in establishing promising therapeutic procedures for keratomycosis.
Literatur
2.
Zurück zum Zitat Gopinathan U, Sharma S, Garg P, Rao GN (2009) Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol 57(4):273–279PubMedCrossRef Gopinathan U, Sharma S, Garg P, Rao GN (2009) Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol 57(4):273–279PubMedCrossRef
3.
Zurück zum Zitat Chang HY, Chodosh J (2011) Diagnostic and therapeutic considerations in fungal keratitis. Int Ophthalmol Clin 51(4):33–42PubMedCrossRef Chang HY, Chodosh J (2011) Diagnostic and therapeutic considerations in fungal keratitis. Int Ophthalmol Clin 51(4):33–42PubMedCrossRef
4.
Zurück zum Zitat Mselle J (1999) Fungal keratitis as an indicator of HIV infection in Africa. Trop Doct 29(3):133–135PubMed Mselle J (1999) Fungal keratitis as an indicator of HIV infection in Africa. Trop Doct 29(3):133–135PubMed
5.
Zurück zum Zitat Thomas PA (2003) Fungal infections of the cornea. Eye (Lond) 17(8):852–862CrossRef Thomas PA (2003) Fungal infections of the cornea. Eye (Lond) 17(8):852–862CrossRef
6.
Zurück zum Zitat Ganegoda N, Rao SK (2004) Antifungal therapy for keratomycoses. Expert Opin Pharmacother 5(4):865–874PubMedCrossRef Ganegoda N, Rao SK (2004) Antifungal therapy for keratomycoses. Expert Opin Pharmacother 5(4):865–874PubMedCrossRef
8.
Zurück zum Zitat Vemuganti GK, Garg P, Gopinathan U, Naduvilath TJ, John RK, Buddi R, Rao GN (2002) Evaluation of agent and host factors in progression of mycotic keratitis: a histologic and microbiologic study of 167 corneal buttons. Ophthalmology 109(8):1538–1546PubMedCrossRef Vemuganti GK, Garg P, Gopinathan U, Naduvilath TJ, John RK, Buddi R, Rao GN (2002) Evaluation of agent and host factors in progression of mycotic keratitis: a histologic and microbiologic study of 167 corneal buttons. Ophthalmology 109(8):1538–1546PubMedCrossRef
9.
Zurück zum Zitat Wollensak G, Sporl E, Seiler T (2003) Treatment of keratoconus by collagen cross linking. Ophthalmologe 100(1):44–49PubMedCrossRef Wollensak G, Sporl E, Seiler T (2003) Treatment of keratoconus by collagen cross linking. Ophthalmologe 100(1):44–49PubMedCrossRef
10.
Zurück zum Zitat Iseli HPTM, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27(5):590–594PubMedCrossRef Iseli HPTM, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27(5):590–594PubMedCrossRef
11.
Zurück zum Zitat Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118(2):324–331PubMedCrossRef Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118(2):324–331PubMedCrossRef
12.
Zurück zum Zitat Makdoumi KMJ, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29(12):1353–1358PubMedCrossRef Makdoumi KMJ, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29(12):1353–1358PubMedCrossRef
13.
Zurück zum Zitat Micelli Ferrari TLM, Lorusso M, Epifani E, Micelli Ferrari L (2009) Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol 19(2):295–297PubMed Micelli Ferrari TLM, Lorusso M, Epifani E, Micelli Ferrari L (2009) Escherichia coli keratitis treated with ultraviolet A/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol 19(2):295–297PubMed
14.
Zurück zum Zitat Moren HMM, Mortensen J, Ohrstrom A (2010) Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29(1):102–104PubMedCrossRef Moren HMM, Mortensen J, Ohrstrom A (2010) Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29(1):102–104PubMedCrossRef
15.
Zurück zum Zitat Lonnen J, Kilvington S, Kehoe SC, Al-Touati F, McGuigan KG (2005) Solar and photocatalytic disinfection of protozoan, fungal and bacterial microbes in drinking water. Water Res 39(5):877–883PubMedCrossRef Lonnen J, Kilvington S, Kehoe SC, Al-Touati F, McGuigan KG (2005) Solar and photocatalytic disinfection of protozoan, fungal and bacterial microbes in drinking water. Water Res 39(5):877–883PubMedCrossRef
16.
Zurück zum Zitat Spoerl EMM, Sliney D, Trokel S, Seiler T (2007) Safety of UVA-riboflavin cross-linking of the cornea. Cornea 26:385–389PubMedCrossRef Spoerl EMM, Sliney D, Trokel S, Seiler T (2007) Safety of UVA-riboflavin cross-linking of the cornea. Cornea 26:385–389PubMedCrossRef
17.
Zurück zum Zitat Ibrahim MM, de Angelis R, Lima AS, Viana de Carvalho GD, Ibrahim FM, Malki LT, de Paula Bichuete M, de Paula Martins W, Rocha EM (2012) A new method to predict the epidemiology of fungal keratitis by monitoring the sales distribution of antifungal eye drops in Brazil. PLoS One 7(3):e33775PubMedCrossRef Ibrahim MM, de Angelis R, Lima AS, Viana de Carvalho GD, Ibrahim FM, Malki LT, de Paula Bichuete M, de Paula Martins W, Rocha EM (2012) A new method to predict the epidemiology of fungal keratitis by monitoring the sales distribution of antifungal eye drops in Brazil. PLoS One 7(3):e33775PubMedCrossRef
18.
Zurück zum Zitat Matsumoto YMD, Kojima T, Shimazaki J, Tsubota K (2011) The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol 95(10):1406–1409PubMedCrossRef Matsumoto YMD, Kojima T, Shimazaki J, Tsubota K (2011) The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol 95(10):1406–1409PubMedCrossRef
19.
Zurück zum Zitat Yavas GFOF, Küsbeci T, Cetinkaya Z, Ermis SS, Kiraz N, Inan UU (2008) Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis. Graefes Arch Clin Exp Ophthalmol 246(2):275–279PubMedCrossRef Yavas GFOF, Küsbeci T, Cetinkaya Z, Ermis SS, Kiraz N, Inan UU (2008) Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis. Graefes Arch Clin Exp Ophthalmol 246(2):275–279PubMedCrossRef
20.
Zurück zum Zitat Martin MJ, Rahman MR, Johnson GJ, Srinivasan M, Clayton YM (1995) Mycotic keratitis: susceptibility to antiseptic agents. Int Ophthalmol 19(5):299–302PubMedCrossRef Martin MJ, Rahman MR, Johnson GJ, Srinivasan M, Clayton YM (1995) Mycotic keratitis: susceptibility to antiseptic agents. Int Ophthalmol 19(5):299–302PubMedCrossRef
21.
Zurück zum Zitat Al-Sabai NKC, Tassignon MJ (2010) UVA/riboflavin crosslinking as treatment for corneal melting. Bull Soc Belge Ophtalmol 315:13–17PubMed Al-Sabai NKC, Tassignon MJ (2010) UVA/riboflavin crosslinking as treatment for corneal melting. Bull Soc Belge Ophtalmol 315:13–17PubMed
22.
Zurück zum Zitat Makdoumi KMJ, Sorkhabi O, Malmvall BE, Crafoord S (2012) UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 250(1):95–102PubMedCrossRef Makdoumi KMJ, Sorkhabi O, Malmvall BE, Crafoord S (2012) UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol 250(1):95–102PubMedCrossRef
23.
Zurück zum Zitat Rama PDMF, Matuska S, Paganoni G, Spinelli A (2009) Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. J Cataract Refract Surg 35(4):788–791PubMedCrossRef Rama PDMF, Matuska S, Paganoni G, Spinelli A (2009) Acanthamoeba keratitis with perforation after corneal crosslinking and bandage contact lens use. J Cataract Refract Surg 35(4):788–791PubMedCrossRef
24.
Zurück zum Zitat Kashiwabuchi RT, Carvalho FR, Khan YA, de Freitas D, Foronda AS, Hirai FE, Campos MS, McDonnell PJ (2011) Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci 52(13):9333–9338PubMedCrossRef Kashiwabuchi RT, Carvalho FR, Khan YA, de Freitas D, Foronda AS, Hirai FE, Campos MS, McDonnell PJ (2011) Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites. Invest Ophthalmol Vis Sci 52(13):9333–9338PubMedCrossRef
25.
Zurück zum Zitat Wiwanitkit V (2010) Bactericidal effect of photo-activated riboflavin using UVA. Graefes Arch Clin Exp Ophthalmol 248(5):755PubMedCrossRef Wiwanitkit V (2010) Bactericidal effect of photo-activated riboflavin using UVA. Graefes Arch Clin Exp Ophthalmol 248(5):755PubMedCrossRef
26.
Zurück zum Zitat del Buey MACJ, Casas P, Goñi P, Clavel A, Mínguez E, Lanchares E, García A, Calvo B (2012) Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol 153(3):399–404PubMedCrossRef del Buey MACJ, Casas P, Goñi P, Clavel A, Mínguez E, Lanchares E, García A, Calvo B (2012) Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates. Am J Ophthalmol 153(3):399–404PubMedCrossRef
27.
Zurück zum Zitat Martins SACJ, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49(8):3402–3408PubMedCrossRef Martins SACJ, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49(8):3402–3408PubMedCrossRef
28.
Zurück zum Zitat Sauer AL-BV, Speeg-Schatz C, Touboul D, Colin J, Candolfi E, Bourcier T (2010) In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci 51(8):3950–3953PubMedCrossRef Sauer AL-BV, Speeg-Schatz C, Touboul D, Colin J, Candolfi E, Bourcier T (2010) In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci 51(8):3950–3953PubMedCrossRef
29.
Zurück zum Zitat Ou JI, Acharya NR (2007) Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin 47(3):7–16PubMedCrossRef Ou JI, Acharya NR (2007) Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin 47(3):7–16PubMedCrossRef
30.
Zurück zum Zitat Ritterband DCSJ, Shah MK, Koplin RS, McCormick SA (2006) Fungal keratitis at the New York eye and ear infirmary. Cornea 25:264–267PubMedCrossRef Ritterband DCSJ, Shah MK, Koplin RS, McCormick SA (2006) Fungal keratitis at the New York eye and ear infirmary. Cornea 25:264–267PubMedCrossRef
31.
Zurück zum Zitat Strober W (2001) Trypan blue exclusion test of cell viability. Curr Protoc Immunol Appendix 3: Appendix 3B Strober W (2001) Trypan blue exclusion test of cell viability. Curr Protoc Immunol Appendix 3: Appendix 3B
32.
Zurück zum Zitat Szentmáry NGS, Bischoff M, Seitz B (2012) Photodynamic therapy for infectious keratitis. Ophthalmologe 109(2):165–170PubMedCrossRef Szentmáry NGS, Bischoff M, Seitz B (2012) Photodynamic therapy for infectious keratitis. Ophthalmologe 109(2):165–170PubMedCrossRef
33.
Zurück zum Zitat Chen ZXS, Zhiqun W, Ran L (2008) In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Br J Ophthalmol 92(9):1283–1286PubMedCrossRef Chen ZXS, Zhiqun W, Ran L (2008) In vitro amoebacidal activity of photodynamic therapy on Acanthamoeba. Br J Ophthalmol 92(9):1283–1286PubMedCrossRef
34.
Zurück zum Zitat Shih MHHF (2011) Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 52(1):223–229PubMedCrossRef Shih MHHF (2011) Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis. Invest Ophthalmol Vis Sci 52(1):223–229PubMedCrossRef
35.
Zurück zum Zitat Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135(5):620–627PubMedCrossRef Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135(5):620–627PubMedCrossRef
36.
Zurück zum Zitat Sudhir PV, Ranjan DS, Ganpat AN (2010) Antifungal agents, WO2009025733. Expert Opin Ther Pat 20(1):137–143PubMedCrossRef Sudhir PV, Ranjan DS, Ganpat AN (2010) Antifungal agents, WO2009025733. Expert Opin Ther Pat 20(1):137–143PubMedCrossRef
37.
Zurück zum Zitat Espinel-Ingroff A (2009) Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005–2009). Rev Iberoam Micol 26(1):15–22PubMedCrossRef Espinel-Ingroff A (2009) Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005–2009). Rev Iberoam Micol 26(1):15–22PubMedCrossRef
38.
Zurück zum Zitat Bartnicki-Garcia S (1968) Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol 22:87–108PubMedCrossRef Bartnicki-Garcia S (1968) Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu Rev Microbiol 22:87–108PubMedCrossRef
39.
Zurück zum Zitat Adams DJ (2004) Fungal cell wall chitinases and glucanases. Microbiology 150(Pt 7):2029–2035PubMedCrossRef Adams DJ (2004) Fungal cell wall chitinases and glucanases. Microbiology 150(Pt 7):2029–2035PubMedCrossRef
40.
Zurück zum Zitat Nakagawa Y (2008) Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells. Microbiol Immunol 52(1):16–24PubMedCrossRef Nakagawa Y (2008) Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells. Microbiol Immunol 52(1):16–24PubMedCrossRef
41.
Zurück zum Zitat Kaplan JGPW (1956) The action of ultraviolet radiation on yeast catalase. J Gen Physiol 40(1):147–169PubMedCrossRef Kaplan JGPW (1956) The action of ultraviolet radiation on yeast catalase. J Gen Physiol 40(1):147–169PubMedCrossRef
42.
Zurück zum Zitat Cornforth JWRG, Robinson PM, Park D (1971) Isolation and characterization of a fungal vacuolation factor (bikaverin). J Chem Soc Perkin 1(16):2786–2788 Cornforth JWRG, Robinson PM, Park D (1971) Isolation and characterization of a fungal vacuolation factor (bikaverin). J Chem Soc Perkin 1(16):2786–2788
43.
Zurück zum Zitat Roberts J (1923) A budrot of the peach caused by a species of fusarium. J Agric Res XXVI(10):507–513 Roberts J (1923) A budrot of the peach caused by a species of fusarium. J Agric Res XXVI(10):507–513
44.
Zurück zum Zitat Taff HT NJ, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR (2012) A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 8:(e1002848): Taff HT NJ, Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR (2012) A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 8:(e1002848):
45.
Zurück zum Zitat Li JHK, Yumoto H, Matsuo T, Miyake Y, Ichikawa T (2010) Enhanced germicidal effects of pulsed UV-LED irradiation on biofilms. J Appl Microbiol 109:2183–2190PubMedCrossRef Li JHK, Yumoto H, Matsuo T, Miyake Y, Ichikawa T (2010) Enhanced germicidal effects of pulsed UV-LED irradiation on biofilms. J Appl Microbiol 109:2183–2190PubMedCrossRef
46.
Zurück zum Zitat Baillie GSDL (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46:397–403PubMedCrossRef Baillie GSDL (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46:397–403PubMedCrossRef
47.
Zurück zum Zitat Marcinkowska JKJ, Marquis LY (1982) Phytotoxic effects of cell-free cultural filtrates of Fusarium solani isolates on virulence, host specificity and resistance. Can J Plant Sci 62:1027–1035CrossRef Marcinkowska JKJ, Marquis LY (1982) Phytotoxic effects of cell-free cultural filtrates of Fusarium solani isolates on virulence, host specificity and resistance. Can J Plant Sci 62:1027–1035CrossRef
Metadaten
Titel
Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration
verfasst von
Renata T. Kashiwabuchi
Fabio R. S. Carvalho
Yasin A. Khan
Flavio Hirai
Mauro S. Campos
Peter J. McDonnell
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2013
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-012-2209-z

Weitere Artikel der Ausgabe 2/2013

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2013 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.